[Edaily Reporter Park Jung-Soo ] Jayjun Cosmetic(025620)is surging on the back of a large-scale, long-term product supply contract. According to MP Doctor on the 23rd, as of 9:14 a.m., CHA AI Healthkare is trading at 7,500 won, up 29.98% (1,730 won) from the previous trading day. After the market closed the previous day, CHA AI Healthkare announced that it had signed a long-term product supply contract worth 52.6 billion won with Nissho Medical. The contract value (5 billion won in the first year, 8.5 billion won in the second year, 12.5 billion won in the third year, 13 billion won in the fourth year, and 13.6 billion won in the fifth year) amounts to 720.05% of last year’s consolidated revenue. The contract period runs through June 22, 2031.
#NEXTBIOMEDICAL CO., LTD., a company specializing in innovative medical devices, has been named to the Korea Exchange’s “KOSDAQ Rising Star” list for the second consecutive year, once again demonstrat…
Celltrion(068270)Celltrion is strengthening its market dominance in Asia—a leading “Shinhung” (emerging pharmaceutical) market—by leveraging its unrivaled direct-to-market competitiveness. While its f…
#
LGCHEM,LTD is set to begin preclinical research on “GNV205,” an antibody-cytokine fusion candidate acquired from the domestic biotech firm GenuV. The company plans to develop it as a next-gen…
